Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3Spoke Capital is a private investment firm focused on structured liquidity solutions for owners of late-stage venture and growth equity assets. The firm works with shareholders, venture funds, limited partners, general partners, and other stakeholders seeking liquidity while preserving exposure to future upside. Its business centers on structured secondary transactions rather than drug development, healthcare services, or life sciences operations. 3Spoke appears to invest broadly in technology-enabled and growth companies and positions itself as a specialist in bespoke private-market liquidity solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3Spoke Capital.